SMAD4 and colonic neoplasm: Similarly in activin treated SMAD4 null SW480 colon cancer cells, NFkB inhibition with wtNBD peptide caused reduced expression of MDM2 paralleled with increased p21 protein expression (Supplementary Figure 4C).